[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100402884":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":14,"centralContacts":19,"locations":26,"responsibleParty":44,"collaborators":46,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":7,"enrollmentInfo":60,"targetDuration":7,"studyType":63,"phases":7,"briefSummary":64,"conditions":65,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"University Health Network, Toronto","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":12},"Medical Cannabis","Verified medical cannabis products available within the current real-world study conform to Health Canada testing requirements",[13],"Medical Marijuana",[15],{"name":16,"affiliation":17,"role":18},"Hance Clarke, MD, PhD","Toronto General Hospital, UHN","PRINCIPAL_INVESTIGATOR",[20],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"Sonal Thaker","CONTACT","416-340-4800 X 4251","4251","sonalben.thaker@uhn.ca",[27],{"facility":17,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Toronto","Ontario","M5G 2C4","Canada","CA",{"type":35,"coordinates":36},"Point",[37,38],-79.39864,43.70643,{"lat":38,"lon":37},[41],{"name":21,"role":22,"phone":42,"phoneExt":24,"email":43},"4163404800","Sonalben.thaker@uhn.ca",{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[47],{"name":48,"class":49},"Avicanna Inc","INDUSTRY","100402884","real-world-evidence-in-patient-reported-outcomes-for-medical-cannabis-mc-rwe-100402884",false,"NCT04526093","Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)","MC-RWE : Real World Evidence in Patient-Reported Outcomes for Medical Cannabis: A Prospective Observational Study","MC-RWE","Inclusion Criteria:\n\n* Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent\n* Primary therapeutic indications for MC use: pain, epilepsy, sleep, and\u002For anxiety\u002Fdepression.\n* Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study\n\nExclusion Criteria:\n\n* Concomitant use of illicit drugs\n* Concomitant use of recreational cannabis","ALL","19 Years",{"count":61,"type":62},1000,"ESTIMATED","OBSERVATIONAL","This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and \u002For anxiety\u002Fdepression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.",[66,67,68,69,70],"Pain","Sleep","Anxiety","Depression","Epilepsy","2026-07-20",{"date":73,"type":74},"2026-07-22","ACTUAL",{"date":76,"type":74},"2020-07-15",{"date":78,"type":62},"2028-07",{"name":5,"class":6},1]